CSI Market
Sign In | Register

Titan Pharmaceuticals Inc (TTNP) Annual Balance Sheets

Annual · GAAP · USD millions
Access TTNP quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Titan Pharmaceuticals Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TTNP/balance-sheets
https://api.csimarket.com/api/v1/companies/TTNP/fundamentals
https://api.csimarket.com/api/v1/companies/TTNP/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent2.83
Cash & Short-term Investments2.00
Accounts receivable0.00
Inventories0.00
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets0.06
Prepaid Expense And Other Assets Current0.03
Total Current Assets2.92
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Restricted Cash-
Operating Lease Right Of Use Asset-
Total Assets2.92
Liabilities
Accounts Payable, Current AC0.20
Other Accrued Liabilities, Current0.28
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities0.48
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Note Payable To Related Party-
Deferred Grant Revenue-
Operating Lease Liability Noncurrent-
Total Liabilities0.48
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock398.97
Retained Earnings / Accumulated Deficit-396.54
Other Equity0.00
Common Stockholder's Equity2.44
Preferred Stockholder's Equity0.00
Total Stockholder's Equity2.44
Liabilities & Stockholder's Equity2.92
4 historic quarters locked

Sign in to unlock the full Titan Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Titan Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001829126-25-001934

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI